Birinci Trimester Gebeliklerin Sonlandırılması İçin Tıbbi Yöntemler
Referanslar
- WHO Call for research proposals/concept papers on Medical Abortion. Accessed from http://www.medicalabortionconsortium.org/events/call-for-research-proposals-conceptpapers-on-medical-abortion-114.html , on 11/10/2010.
- Shah I, Ahman E. Unsafe abortion: global and regional incidence, trends, consequences,andchallenges. J Obstet Gynaecol Can 2009;31(12):1149-1158.
- Sedgh G, Henshaw S, Singh S, Ahman E, Shah IH. Induced abortion: estimated rates and trends worldwide. Lancet 2007;370(9595):1338-1345.
- Johnston Wm R. Comments on abortion. Accessed from statistics.http://www.johnstonsarchive.net/policy/abortion/index.html#CM, on 21/10/2010.
- Borgatta L, Stubblefield PG. Surgical Techniques for First-Trimester Abortion. Accessed from http://www.glowm.com/?p=glowm.cml/section_view&articleid=439&SESSID=u52p1hf6r68okelim1ssufm6s7, on 11/10/2010.
- Akın A, Doğan G, Dilbaz B, Gökkurt K, Coşkun S, Beyhun A, Erdost E, Temel TF. Türkiye İçin Yeni Bir Seçenek: Tıbbi Düşükler, Ankara, Hacettepe Üniversitesi Tıp Fakültesi Halk Sağlığı Anabilim Dalı Yayını, 2005.
- Dickerson V. American College of Obstetricians and Gynecologists. ACOG letter on. Accessed from http://www.acog. safety of RU-486, 7 December 2004 [news release]. org/from_home/publications/press_releases/nr12-07-04.cfm, on 05/09/2010.
- Faucher B, Baunot N, Madelenat P. The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked to the hospital: a prospective study of 433 patients. Gynecol Obstet Fertil 2005;33:220-227.
- Ibis Reproductive Health Mifepristone and misoprostol regimen. Accessed from http://medicationabortion.com/mifepristone/index.html , on 11/10/2010.
- World Health Organization. Safe abortion: technical and policy guidance for health systems. Geneva, World Health Organization. 2003.
- Tuzcular Vural Z, Gönenç I, Köse G, Tüfekçi EC, Aka N. Offering women options for terminatýon of fýrst trimester pregnancy: medical versus surgical methods. 11th Congress of the European Society of Contraception.19-22 May 2010. Programme and Book of Abstracts. The Hague, The Netherlands.
- Akin A, Blum J, Ozalp S, Onderoðlu L, Kirca U, Bilgili N, Koçoğlu G, Philip N, Winikoff B. Results and Lessons learned from a small medical abortion clinical study in Turkey. Contraception 2004;70(5):401-464.
- Coeytaux F, Moore K, Gelberg L. Convincing new providers to offer medical abortion: what will it take? Perspectives on Sexual and Reproductive Health 2003;35(1):44-47.
- Schreiber CA, Creinin MD, Harwood B, Murthy AS. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days. Contraception 2005; 71: 447-450.
- Faucher B, Baunot N, Madelenat P. The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked to the hospital: a prospective study of 433 patients. Gynecol Obstet Fertil 2005;33:220-227.
- Loeber OE.Motivation and satisfaction with early medical vs. surgical abortion in the Netherlands. Reprod Health Matters. 2010;18(35):145-153.